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Three-component synthesis, utilization and
biological activity of phosphinoyl-functionalized
isoindolinones†
Nóra Popovics-Tóth,a Bettina Rávai,a Ádám Tajti,a Bence Varga, a Péter Bagi, a
Franc Perdih, b Pál Tamás Szabó, c László Hackler, Jr.,d László G. Puskásd and
Erika Bálint *a
A new method for the synthesis of 3-oxoisoindolin-1-ylphosphine oxides bearing same or different sub-
stituents on the phosphorus atom is described. The one-pot three-component reaction of 2-formylben-
zoic acid, primary amines and achiral or P-stereogenic secondary phosphine oxides provided the target
compounds under catalyst-free, mild conditions and for short reaction times. The deoxygenation of a
3-oxoisoindolin-1-ylphosphine oxide was also studied, and the phosphine obtained could be converted
to a sulphide and to a platinum complex. The crystal structures of a selected phosphine oxide and the
corresponding platinum species were investigated by X-ray diffraction analysis. The biological activity,
such as in vitro cytotoxicity on different cell lines and antibacterial activity of the 3-oxoisoindolin-1-ylpho-
sphine oxides was also investigated. Based on the IC50 values obtained, several derivatives showed mo-
derate activity against the HL-60 cell line and two compounds containing 3,5-dimethylphenyl groups on
the phosphorus atom showed promising activity against Bacillus subtilis bacteria.
Introduction
Nitrogen-heterocycles as one of the major classes of organic
compounds play an important role in scientific research.
Several papers reported on their synthesis, emphasizing their
biological properties as pharmaceuticals or agrochemicals and
their utilization as dyes.1
Isoindolin-1-ones as naturally occurring and pharmacologi-
cally relevant N-heterocycles have attracted considerable atten-
tion.2 They may possess a variety of biological activities,
including antiviral,3 anti-inflammatory and antipsychotic4 pro-
perties. A few derivatives have also been reported to be
effective for treating cancer,5 arrhythmia6 and diabetes.7
Compounds containing both an isoindolinone scaffold and
a phosphonate moiety, such as 3-oxoisoindolin-1-ylphospho-
nates, can act as bioisosteres of natural α-amino acids, and
may often show biological effects,8 such as they may be used
as pesticides.9
Multicomponent reactions continuously attract great atten-
tion as one of the most useful and efficient tools for the syn-
thesis of versatile heterocyclic compounds.10 The following
advantages can be highlighted from the numerous benefits of
this synthetic strategy. Products are usually formed in a single
step from simple starting materials in high atom efficient reac-
tions. The possibility of applying diverse reagents makes them
ideal for creating new molecular libraries. Moreover, in most
cases, the principles of green chemistry also prevail to save
time and energy.
In recent years, many efforts have been made to synthesize
isoindolin-1-ones.2,11 However, only a few methods have been
reported for the preparation of 3-oxoisoindolin-1-ylphospho-
nates. Ordóñez and his research group described a microwave
(MW)-assisted special Kabachnik–Fields reaction of 2-formyl-
benzoic acid, dimethyl phosphite and as the third component,
aromatic amines,12 aminoacetaldehyde dimethyl acetal13 or
amino alcohols.14 They also studied the condensation with
optically active amines under conventional heating.15 Others
reported syntheses in the presence of a special catalyst or addi-
tive, such as NaH,16 T3P®17 or OSU-618 in MeOH, EtOAc or
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EtOH, respectively. In our previous study, we have described
an efficient catalyst-free method for the batch and continuous
flow synthesis of 3-oxoisoindolin-1-ylphosphonates (1) contain-
ing alkyl substituents on the nitrogen atom by the three-com-
ponent reaction of 2-formylbenzoic acid, aliphatic primary
amines and dialkyl phosphites or ethyl phenyl-H-phosphi-
nate19 (Scheme 1).
3-Oxoisoindolin-1-ylphosphine oxides are much less
studied; they have only been mentioned in the literature as
intermediates. Couture and co-workers prepared
α-amidophosphine oxides 3 by three different methods
(method A, B or C), and carried out their ring closure reaction
in the presence of potassium bis(trimethylsilyl)amide
(KHMDS) and 18-crown-6 (Scheme 2).20
Deniau and co-workers developed an asymmetric synthesis
of diarylphosphine oxide-substituted isoindolinones bearing
an (S)-2-alkoxymethyl-pyrrolidin-1-yl type auxiliary (6) by a
three-step reaction starting from phthalic anhydride and (S)-1-
amino-2-alkyloxymethylpyrrolidine (5) (Scheme 3).21
Both approaches applied multistep syntheses using
complex and/or expensive reagents and required special
treatments.
To the best of our knowledge, there is no example in the lit-
erature for the synthesis of 3-oxoisoindolin-1-ylphosphine
oxides by a multicomponent reaction, and their utilization has
not been investigated yet.
In this paper, we describe the first multicomponent syn-
thetic method for the preparation of 3-oxoisoindolin-1-ylpho-
sphine oxides containing the same or different substituents on
the phosphorus atom. Our approach is based on the three-
component reaction of 2-formylbenzoic acid, primary amines
and achiral or P-chiral secondary phosphine oxides, and this
method required neither catalyst/additive nor special con-
ditions. We have also investigated the utilization of a 3-oxoi-
soindolin-1-ylphosphine oxide as a phosphine ligand precur-
sor. After deoxygenation, the 3-oxoisoindolin-1-ylphosphine
obtained was applied as a ligand in the synthesis of a mono-
dentate platinum(II) complex. In addition, the in vitro cyto-
toxicity and antibacterial activity of the title compounds were
also studied.
Results and discussion
At first, the special Kabachnik–Fields reaction of 2-formylben-
zoic acid, primary amines (butyl-, cyclohexyl-, benzylamine or
aniline) and diphenylphosphine oxide was investigated
without any catalyst (Table 1). Carrying out the condensation
Scheme 1 Synthesis of 3-oxoisoindolin-1-ylphosphonates (1) by special Kabachnik–Fields reaction.
Scheme 2 Preparation of 3-oxoisoindolin-1-ylphosphine oxides (4) by ring closure reaction.
Scheme 3 Asymmetric synthesis of diarylphosphine oxide-substituted isoindolinones.
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with butylamine in the absence of any solvent at room temp-
erature for 5 min, 58% of diphenyl (2-butyl-3-oxo-2,3-dihydro-
2H-isoindol-1-yl)phosphine oxide (7a) was formed (Table 1,
entry 1). To improve the conversion, a small amount of solvent
was added to overcome the heterogeneity of the reaction
mixture. Among tested solvents (ethanol, toluene and aceto-
nitrile), acetonitrile was the most efficient, since a conversion
of 88% was achieved (Table 1, entries 2–4). Increasing the reac-
tion time to 10 min, the reaction was complete (Table 1, entry
5). The acetonitrile and the water formed were eliminated in
vacuum, and the crude product was passed through short plug
of silica to obtain product 7a in a yield of 98%. Starting from
cyclohexylamine, the condensation was not complete after
10 min, and the conversion was only 83% (Table 1, entry 6).
Applying longer reaction time of 15 or 20 min, led to a pro-
portion of 91% and 100% of the desired product (7b), respect-
ively (Table 1, entries 7 and 8). The decrease in the reaction
rate may be caused by the larger steric hindrance of the cyclo-
hexyl ring. The diphenyl (2-cyclohexyl-3-oxo-2,3-dihydro-2H-iso-
indol-1-yl)phosphine oxide (7b) was isolated in a yield of 94%.
In case of benzylamine or aniline, a reaction time of 10 min
was enough for a complete conversion similarly to the conden-
sation of butylamine (Table 1, entries 5, 9 and 10). The corres-
ponding 3-oxoisoindolin-1-ylphosphine oxides (7c and 7d)
were obtained in yields of 97% and 96%, respectively.
Next, the three-component reaction of 2-formylbenzoic acid
with a wide range of primary amines and secondary phosphine
oxides was investigated using the optimized conditions (25 °C,
10–20 min) (Scheme 4). Performing the condensation of 2-for-
mylbenzoic acid, butylamine and bis(p-tolyl)-, bis(3,5-di-
methylphenyl)- or bis(2-naphthyl)phosphine oxide, the corres-
ponding 3-oxoisoindolin-1-ylphosphine oxides (8a–10a) were
prepared in yields of 96–99%. Dibenzylphosphine oxide was
also used as the P-reagent. In this case, a slightly increased
reaction time of 15 min was necessary to reach full conversion,
and the dibenzyl (2-butyl-3-oxo-2,3-dihydro-2H-isoindol-1-yl)
phosphine oxide (11a) was isolated in a yield of 96%. Carrying
out the reaction of 2-formylbenzoic with cyclohexylamine and
the secondary phosphine oxides mentioned above, the conden-
sations were slightly slower (20 or 25 min). The desired 3-oxoi-
soindolin-1-ylphosphine oxides (8b–11b) were also obtained in
high yields (94–97%). Applying benzylamine or aniline as the
amine component, the reactions took place similarly to that
with butylamine, and the corresponding products (8c–11c, 8d
and 9d) were synthesized in yields of 96–98%.
In the next series of experiments, the special Kabachnik–
Fields reaction of 2-formylbenzoic acid and butylamine was
extended using P-stereogenic phosphine oxides, such as tert-
butyl(phenyl)phosphine oxide, 2-methylphenyl(phenyl)-phos-
phine oxide, 2-methoxyphenyl(phenyl)phosphine oxide, 2-, 3-
or 4-trifluoromethylphenyl(phenyl)phosphine oxide, as well as
biphenyl(phenyl)phosphine oxide or 1-naphthyl(phenyl)phos-
Table 1 Optimization of the three-component reaction of 2-formyl-
benzoic acid, primary amines and diphenylphosphine oxidea
Entry Solvent R t [min] Conversionb [%] Yieldc [%]
1 — Bu 5 58 —
2 EtOH Bu 5 79 —
3 PhMe Bu 5 82 —
4 MeCN Bu 5 88 —
5 MeCN Bu 10 100 98 (7a)
6 MeCN cHex 10 83 —
7 MeCN cHex 15 91 —
8 MeCN cHex 20 100 94 (7b)
9 MeCN Bn 10 100 97 (7c)
10 MeCN Ph 10 100 96 (7d)
a The reactions were carried out with 1.0 mmol of 2-formylbenzoic
acid, 1.0 mmol of primary amine and 1.0 mmol of diphenylphosphine
oxide in the absence of any solvent or in 1 mL of solvent. bDetermined
by HPLC (222 nm). c Isolated yield.
Scheme 4 Three-component reaction of 2-formylbenzoic acid,
primary amines and achiral phosphine oxides. (The reaction was per-
formed with 1.0 mmol of 2-formylbenzoic acid, 1.0 mmol of amine and
1.0 mmol of secondary phosphine oxide in 1 mL of acetonitrile at 25 °C.
The listed yield is isolated yield.)
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phine oxide (Scheme 5). The condensations were performed at
25 °C, for 10 or 20 min without any catalyst in acetonitrile,
according to the method described above. Altogether eight
3-oxoisoindolin-1-ylphosphine oxides (12–19) having different
substituents on the phosphorus atom were synthesized in
excellent yields (94–98%). Due to the P-stereogenic centre in
the P-functionality, all products (12–19) were formed as a
mixture of two diastereomers, and both diastereomers were
racemates. Therefore, two signals were observed in the 31P
NMR spectra, and two signals were visible in the 13C and 1H
NMR spectra. However, the diastereomeric ratio (dr) of the
compounds synthesized was different. Most of the 3-oxoisoin-
dolin-1-ylphosphine oxides (12–14, 16, 18 and 19) were
obtained as a 40 : 60 or 45 : 55 mixture of the diastereomers
based on the 31P NMR spectra. Compound 17 incorporating a
4-trifluormethyl group on the phosphorus atom was formed as
an equal (50 : 50) mixture of diastereomers. The condensation
was more diastereoselective, when 2-trifluormethylphenyl-
(phenyl)phosphine oxide was used as the P-reagent, in this
case, the diastereomeric ratio was 35 : 65. Due to the bigger
difference of the functional groups on the phosphorus atom of
1-naphthyl(phenyl) (2-butyl-3-oxo-2,3-dihydro-2H-isoindol-1-yl)
phosphine oxide (19), the diastereomers were successfully se-
parated by column chromatography.
Altogether, 26 3-oxoisoindolin-1-ylphosphine oxides (7–19)
were prepared in high yields at ambient temperature for short
reaction times (10–25 min), and fully characterized by 31P, 13C
and 1H NMR spectroscopy, as well as by HRMS.
As the next step, the diphenyl (2-butyl-3-oxo-2,3-dihydro-2H-
isoindol-1-yl)phosphine oxide (7a) was utilized as a precursor
for a monodentate P-ligand in the synthesis of a platinum
complex. First, the deoxygenation of 7a was studied applying
phenylsilane as a reducing agent under microwave (MW)
irradiation in the absence of any catalyst and solvent (Table 2).
The phosphine (20) obtained was immediately converted to a
sulphide (21), and the mixture was analyzed by HPLC-MS and
31P NMR. Performing the reaction at 100 °C for 2 h, the
reduction was not complete (Table 2, entry 1). Applying a
higher temperature of 140 °C for 4 h, the conversion signifi-
cantly increased to 60% (Table 2, entry 2). After an irradiation
of 6 h, the reduction was complete, and the sulphide (21) was
isolated in a yield of 81% after column chromatography
(Table 2, entry 3).
Finally, the diphenyl (2-butyl-3-oxo-2,3-dihydro-2H-isoindol-
1-yl)phosphine (20) obtained after deoxygenation was con-
verted to a monodentate platinum(II) complex (22) by the reac-
tion with 0.5 equiv. of dichlorodibenzonitrile platinum at
25 °C in dichloromethane (Scheme 6). The platinum(II)
complex (22) could be isolated in a yield of 80% by column
chromatography, and it was characterized by 31P, 13C, 1H NMR
and HRMS, as well as by single crystal X-ray diffraction
analysis.
The relative spatial orientation (cis or trans) of platinum-
phosphine coordination compounds can be inferred from the
Scheme 6 Synthesis of the platinum(II) complex of diphenyl (2-butyl-3-
oxo-2,3-dihydro-2H-isoindol-1-yl)phosphine. (The reaction was carried
out with 1.0 mmol of 20 and 0.5 mmol of bis(benzonitrile)dichloroplati-
num in 10 mL of degassed dichloromethane.)
Scheme 5 Three-component reaction of 2-formylbenzoic acid, butyla-
mine and P-chiral phosphine oxides. (The reaction was performed with
1.0 mmol of 2-formylbenzoic acid, 1.0 mmol of butylamine and
1.0 mmol of secondary phosphine oxide in 1 mL of acetonitrile at 25 °C.
The listed yield is isolated yield.)
Table 2 Deoxygenation of diphenyl (2-butyl-3-oxo-2,3-dihydro-2H-
isoindol-1-yl)-phosphine oxide (7a) and formation of sulphide 21a
Entry T [°C] t [h] Conversionb [%] Yieldc [%]
1 100 2 17 —
2 140 4 60 —
3 140 6 100 81 (21)
a First step of the reaction was performed with 1.0 mmol of 7a and
3.0 mmol of phenylsilane without any solvent under N2 atmosphere in
a microwave reactor. In the second step, 1.2 mmol of sulphur in 10 mL
of degassed DCM was added to 20. bDetermined by 31P NMR. c After
column chromatography.
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magnitude of the stereospecific platinum-phosphorus coup-
ling constant (1JPt–P) in the
31P NMR spectrum. It is known
from the literature that the 1JPt–P coupling constant is between
3400 to 3600 Hz for cis arrangements, while trans complexes
display typical 1JPt–P coupling constants of 2500–3000 Hz.
22
The 1JPt–P coupling constant was 2519 Hz, which means
that the trans platinum complex ((trans)-22) was formed.
Moreover, in the 31P NMR spectrum of the platinum(II)
complex ((trans)-22), two very close peaks in a ratio of ca. 1 : 1
and their satellites could be observed. As the isoindolinone
ring contains a stereogenic centre, the platinum complex
((trans)-22) was obtained as a mixture of a homochiral and he-
terochiral diastereomer.
Single-crystal XRD analysis was used to reveal the molecular
structures of 7a and 22 (Fig. 1). In the crystal lattice, 7a, mole-
cules are connected into a hydrogen-bonded chain through
C–H⋯OvP interactions along the c-axis, and these chains are
further connected into 3D network via C–H⋯O2 interactions
with the isoindolin-1-one oxygen atom as well as C–H⋯π inter-
actions (Fig. S1 and Table S2†). The XRD analysis also con-
firmed the trans geometry in platinum complex 22. A hydro-
gen-bound layer is formed through the C–H⋯O1 interactions,
and a 3D network is achieved via C–H⋯π interactions (Fig. S2
and Table S2†).
The biological activity, such as in vitro cytotoxicity and anti-
bacterial activity of 3-oxoisoindolin-1-ylphosphine oxides
bearing the same substituents on the phosphorus atom (7–11)
were also studied. Cytotoxicity assays used the human lung
adenocarcinoma A549 cell line, the mouse fibroblast NIH/3T3
as a healthy cell line and the human promyelocytic leukemia
HL-60 cell line. During the measurements, the fluorescent
Resazurin assay as described previously was applied.23 For the
A549 and NIH/3T3 cell lines, doxorubicin was the positive
control (IC50 = 0.31 ± 0.24 µM and 5.65 ± 0.81 µM, respect-
ively), while for HL60, it was bortezomib (IC50 = 7.42 ± 2.60
nM). The antibacterial activity of the compounds was investi-
gated on green fluorescent protein (GFP) producing Bacillus
subtilis (Gram–positive) and Escherichia coli (Gram–negative)
bacterial cells. The GFP producing bacteria are efficient tools
for screening the antibacterial activity, since the GFP signal
measured by fluorimetry is proportional to the number of the
bacterial cells. Active compounds kill bacterial cells, which
decreases the GFP fluorescence signal, therefore it is con-
venient for evaluating the antimicrobial effect of different
agents. Positive controls were doxycycline and gentamicin for
Bacillus subtilis (IC50 = 0.126 ± 0.029 µM and 0.115 ± 0.001 µM)
and for Escherichia coli (IC50 = 0.10 ± 0.02 µM and 4.23 ±
0.99 µM) bacterial cells. The IC50 values (50% inhibiting con-
centration) obtained are shown in Table 3.
According to the results, those (3-oxo-2,3-dihydro-2H-isoin-
dol-1-yl)phosphine oxides (8–10) showed activity to some
extent, which contain substituted phenyl groups (p-tolyl or 3,5-
dimethylphenyl) or naphthyl rings on the phosphorus atom.
Among the bis(p-tolyl) (3-oxo-2,3-dihydro-2H-isoindol-1-yl)
phosphine oxides, only the N-butyl substituted derivative (8a)Fig. 1 Molecular structures of compounds 7a and (trans)-22.
Table 3 In vitro cytotoxicity and antibacterial activity of (3-oxo-2,3-dihydro-2H-isoindol-1-yl)phosphine oxidesa
Compound R
In vitro cytotoxicity [IC50, µM] Antibacterial activity [IC50, μM]
A549 NIH/3T3 HL-60 B. subtilis E. coli
Bu (8a) >30 >30 25.03 ± 2.07 >10 >10
cHex (8b) >30 >30 >30 >10 >10
Bn (8c) >30 >30 >30 >10 >10
Bu (9a) >30 >30 17.55 ± 1.70 4.60 ± 1.13 >10
cHex (9b) >30 >30 >30 >10 >10
Bn (9c) >30 >30 18.31 ± 1.33 3.61 ± 1.25 >10
Bu (10a) 28.2 ± 1.05 25.94 ± 1.06 12.26 ± 1.02 >10 >10
cHex (10b) >30 >30 28.81 ± 1.17 >10 >10
Bn (10c) >30 >30 25.61 ± 1.12 >10 >10
Doxorubicin 0.31 ± 0.24 5.65 ± 0.81 — — —
Bortezomib — — 7.42 × 10−3 ± 2.60 × 10−3 — —
Doxycycline — — — 0.126 ± 0.029 0.10 ± 0.02
Gentamicin — — — 0.115 ± 0.001 4.23 ± 0.99
aData were expressed as mean ± standard deviation.
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showed modest activity against HL-60 cell line (IC50 = 25.03 ±
2.07 µM). In case of bis(3,5-dimethylphenyl) (3-oxo-2,3-
dihydro-2H-isoindol-1-yl)phosphine oxides, compounds con-
taining butyl (9a) or benzyl (9c) group on the nitrogen atom
were slightly effective against HL-60 cells. Furthermore, these
3-oxoisoindolin-1-ylphosphine oxides (9a and 9c) also showed
promising antibacterial activity, since the growth of Bacillus
subtilis bacteria was reduced by them, and the IC50 values
obtained (4.60 ± 1.13 µM and 3.61 ± 1.25 µM) were slightly
close to the value of doxycycline and gentamicin, respectively.
Among the derivatives containing 2-naphthyl groups on the
phosphorus atom, compounds 10b and 10c were rather active
against HL-60 cells. In contrast, the bis(2-naphthyl) (2-butyl-3-
oxo-2,3-dihydro-2H-isoindol-1-yl)-phosphine oxide (10a)
showed cytotoxicity against all the three cell lines, and the best
activity was showed against HL-60 cells (12.26 ± 1.02).
The most active compounds were the bis(3,5-dimethyl-
phenyl) (2-butyl-3-oxo-2,3-dihydro-2H-isoindol-1-yl)phosphine
oxide (9a) and the bis(3,5-dimethylphenyl) (2-benzyl-3-oxo-2,3-
dihydro-2H-isoindol-1-yl)phosphine oxide (9c), since they
showed activity in the 3–4 µM range against Gram positive
bacteria.
Conclusions
In conclusion, we have developed a new and practical catalyst-
free method to novel phosphinoyl-functionalized isoindolin-1-
ones (7–19) by the special Kabachnik–Fields reaction of 2-for-
mylbenzoic acid, primary amines and achiral or P-chiral sec-
ondary phosphine oxides at ambient temperature for short
reaction times (10–25 min). This procedure means a promising
approach to attain these new heterocycles, since it applies
mild and easily operational conditions (no special reagents,
catalysts or additives, no heating). Altogether 26 new 3-oxoi-
soindolin-1-ylphosphine oxides (7–19) were synthesized in
high to excellent yields and these derivatives were fully charac-
terized. One of the 3-oxoisoindolin-1-ylphosphine oxides (7a)
has been utilized as P-ligand for the synthesis of a monoden-
tate platinum complex (trans-22). The crystal structure of com-
pound 7a and platinum(II) complex 22 was studied by single-
crystal XRD analysis. The biological activity of the (3-oxo-2,3-
dihydro-2H-isoindol-1-yl)phosphine oxides (7–11) was also
tested in in vitro cytotoxicity and antibacterial assays. Several
3-oxoisoindolin-1-ylphosphine oxides showed modest activity
against HL-60 cell line, furthermore, two derivatives 9a and 9c
incorporating 3,5-dimethylphenyl groups on the phosphorus
atom were also active against selected Gram-positive bacteria.
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